首页> 外文期刊>ACS applied materials & interfaces >In vitro Studies and Preliminary In vivo Evaluation of Silicified Concentrated Collagen Hydrogels
【24h】

In vitro Studies and Preliminary In vivo Evaluation of Silicified Concentrated Collagen Hydrogels

机译:硅化浓缩胶原蛋白水凝胶的体外研究和初步体内评价

获取原文
获取原文并翻译 | 示例
       

摘要

Hybrid and nanocomposite silica-collagen materials derived from concentrated collagen hydrogels were evaluated in vitro and in vivo to establish their potentialities for biological dressings. Silicification significantly improved the mechanical and thermal stability of the collagen network within the hybrid systems. Nanocomposites were found to favor the metabolic activity of immobilized human dermal fibroblastswhile decreasing the hydrogel contraction. Cell adhesion experiments suggested that in vitro cell behavior was dictated by mechanical properties and surface structure of the scaffold. First-to-date in vivo implantation of bulk hydrogels in subcutaneous sites of rats was performed over the vascular inflammatory period. These materials were colonized and vascularized without inducing strong inflammatory response. These data raise reasonable hope for the future application of silica-collagen biomaterials as biological dressings.
机译:在体外和体内对源自浓缩胶原蛋白水凝胶的杂化和纳米复合二氧化硅胶原材料进行了评估,以建立其生物敷料的潜力。硅化作用显着改善了混合系统中胶原网络的机械和热稳定性。发现纳米复合材料有利于固定的人皮肤成纤维细胞的代谢活性,同时减少水凝胶收缩。细胞粘附实验表明,体外细胞行为取决于支架的机械性能和表面结构。在血管炎期间,将大批水凝胶首次体内植入大鼠皮下部位。这些材料被定殖和血管化而不会引起强烈的炎症反应。这些数据为二氧化硅-胶原生物材料作为生物敷料的未来应用带来了合理的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号